Dr. Sam Sanders, internist at Bellevue Hospital in NYC, takes us through a case-based review of metabolic dysfunction–associated steatotic liver disease (MASLD), an increasingly common condition. We cover updated terminology, risk stratification using FIB-4 scoring and FibroScans, indications for hepatology referral, and new management strategies to prevent fibrosis progression and cirrhosis.

Our Sponsors:
* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com


Advertising Inquiries: https://redcircle.com/brands